Capsule Commentary on Turner et al., Chronic Opioid Therapy Risk Reduction Initiative: Impact on Urine Drug Testing Rates and Results

Documents similaires

• Capsule Commentary on Turner et al., Chronic Opioid Therapy Urine Drug Testing in Primary Care: Prevalence and Predictors of Aberrant Results
  par: Chiovaro, Joseph
  Publié: (2014)
• Capsule Commentary on Sullivan et al., Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction
  par: Chen, Jessica A.
  Publié: (2019)
• Erratum to: Capsule commentary on Turner, et al. Chronic opioid therapy urine drug testing in primary care: prevalence and predictors of aberrant results
  par: Chiovaro, Joseph
  Publié: (2015)
• Capsule Commentary on Shultz et al., Patient Preferences for Test Result Notification
  par: Witteman, Holly O.
  Publié: (2015)
• Capsule Commentary on Calcaterra et al., Opioid Prescribing at Hospital Discharge Contributes to Chronic Opioid Use
  par: Subramani, Matthew S.
  Publié: (2016)